(Q37568972)

21 August 2017

1 reference

title

Cutaneous melanoma in the era of molecular profiling (English)

1 reference

21 August 2017

2

1 reference

21 August 2017

John F Thompson

1

1 reference

21 August 2017

Richard F Kefford

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

374

1 reference

21 August 2017

issue

9687

1 reference

21 August 2017

page(s)

362-365

1 reference

Distinct sets of genetic alterations in melanoma

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Oncogenic Braf induces melanocyte senescence and melanoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Improving melanoma classification by integrating genetic and morphologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Sentinel-node biopsy or nodal observation in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Immunotherapy: Vaccine trials in melanoma -- time for reflection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with tremelimumab (CP-675,206).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961397-0

7 January 2021

10.1016/S0140-6736(09)61397-0

Identifiers

DOI

1 reference

21 August 2017

1 reference